Tilray (NASDAQ:TLRY) Trading 0.8% Higher

Tilray Inc (NASDAQ:TLRY)’s share price was up 0.8% during trading on Thursday . The stock traded as high as $1.88 and last traded at $1.85. Approximately 5,565,599 shares were traded during trading, a decline of 79% from the average daily volume of 26,285,965 shares. The stock had previously closed at $1.83.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. CIBC lowered their price target on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th. Alliance Global Partners boosted their price target on shares of Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research note on Friday, April 5th. Finally, Canaccord Genuity Group lowered their price objective on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th.

Tilray Price Performance

The stock has a market capitalization of $1.43 billion, a PE ratio of -4.19 and a beta of 2.19. The firm’s 50 day simple moving average is $1.82 and its 200 day simple moving average is $1.93. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18.

Hedge Funds Weigh In On Tilray

Large investors have recently bought and sold shares of the stock. Gainplan LLC bought a new position in shares of Tilray in the fourth quarter worth approximately $28,000. Simplicity Wealth LLC purchased a new position in shares of Tilray in the first quarter valued at about $28,000. RPO LLC bought a new position in shares of Tilray during the fourth quarter valued at about $28,000. Wellington Wealth Strategies LLC. purchased a new stake in shares of Tilray during the fourth quarter worth about $29,000. Finally, International Assets Investment Management LLC grew its stake in shares of Tilray by 179.0% in the fourth quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock worth $34,000 after purchasing an additional 9,453 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.